BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 29028353)

  • 1. Activated Microglia Targeting Dendrimer-Minocycline Conjugate as Therapeutics for Neuroinflammation.
    Sharma R; Kim SY; Sharma A; Zhang Z; Kambhampati SP; Kannan S; Kannan RM
    Bioconjug Chem; 2017 Nov; 28(11):2874-2886. PubMed ID: 29028353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic dendrimer-drug nanomedicines for long-term treatment of mild-moderate cerebral palsy in a rabbit model.
    Zhang Z; Lin YA; Kim SY; Su L; Liu J; Kannan RM; Kannan S
    J Neuroinflammation; 2020 Oct; 17(1):319. PubMed ID: 33100217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendrimer mediated targeted delivery of sinomenine for the treatment of acute neuroinflammation in traumatic brain injury.
    Sharma R; Kambhampati SP; Zhang Z; Sharma A; Chen S; Duh EI; Kannan S; Tso MOM; Kannan RM
    J Control Release; 2020 Jul; 323():361-375. PubMed ID: 32339548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory and anti-oxidant activity of anionic dendrimer-N-acetyl cysteine conjugates in activated microglial cells.
    Wang B; Navath RS; Romero R; Kannan S; Kannan R
    Int J Pharm; 2009 Jul; 377(1-2):159-68. PubMed ID: 19463931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential and Increased Uptake of Hydroxyl-Terminated PAMAM Dendrimers by Activated Microglia in Rabbit Brain Mixed Glial Culture.
    Alnasser Y; Kambhampati SP; Nance E; Rajbhandari L; Shrestha S; Venkatesan A; Kannan RM; Kannan S
    Molecules; 2018 Apr; 23(5):. PubMed ID: 29702566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Mitochondrial Dysfunction and Oxidative Stress in Activated Microglia using Dendrimer-Based Therapeutics.
    Sharma A; Liaw K; Sharma R; Zhang Z; Kannan S; Kannan RM
    Theranostics; 2018; 8(20):5529-5547. PubMed ID: 30555562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of mannose targeting of hydroxyl PAMAM dendrimers on cellular and organ biodistribution in a neonatal brain injury model.
    Sharma A; Porterfield JE; Smith E; Sharma R; Kannan S; Kannan RM
    J Control Release; 2018 Aug; 283():175-189. PubMed ID: 29883694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodistribution of fluorescently labeled PAMAM dendrimers in neonatal rabbits: effect of neuroinflammation.
    Lesniak WG; Mishra MK; Jyoti A; Balakrishnan B; Zhang F; Nance E; Romero R; Kannan S; Kannan RM
    Mol Pharm; 2013 Dec; 10(12):4560-71. PubMed ID: 24116950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of dendrimer-drug by different cell types in the hippocampus after hypoxic-ischemic insult in neonatal mice: Effects of injury, microglial activation and hypothermia.
    Nemeth CL; Drummond GT; Mishra MK; Zhang F; Carr P; Garcia MS; Doman S; Fatemi A; Johnston MV; Kannan RM; Kannan S; Wilson MA
    Nanomedicine; 2017 Oct; 13(7):2359-2369. PubMed ID: 28669854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic dendrimer-drug treatment of ischemia-induced neonatal white matter injury.
    Nance E; Porambo M; Zhang F; Mishra MK; Buelow M; Getzenberg R; Johnston M; Kannan RM; Fatemi A; Kannan S
    J Control Release; 2015 Sep; 214():112-20. PubMed ID: 26184052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendrimer brain uptake and targeted therapy for brain injury in a large animal model of hypothermic circulatory arrest.
    Mishra MK; Beaty CA; Lesniak WG; Kambhampati SP; Zhang F; Wilson MA; Blue ME; Troncoso JC; Kannan S; Johnston MV; Baumgartner WA; Kannan RM
    ACS Nano; 2014 Mar; 8(3):2134-47. PubMed ID: 24499315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoscale effects in dendrimer-mediated targeting of neuroinflammation.
    Nance E; Zhang F; Mishra MK; Zhang Z; Kambhampati SP; Kannan RM; Kannan S
    Biomaterials; 2016 Sep; 101():96-107. PubMed ID: 27267631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendrimer-enabled targeted delivery attenuates glutamate excitotoxicity and improves motor function in a rabbit model of cerebral palsy.
    Zhang F; Zhang Z; Alt J; Kambhampati SP; Sharma A; Singh S; Nance E; Thomas AG; Rojas C; Rais R; Slusher BS; Kannan RM; Kannan S
    J Control Release; 2023 Jun; 358():27-42. PubMed ID: 37054778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of inflammatory signaling and cytokine release from microglia by celastrol incorporated into dendrimer nanocarriers.
    Boridy S; Soliman GM; Maysinger D
    Nanomedicine (Lond); 2012 Aug; 7(8):1149-65. PubMed ID: 22475649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dense hydroxyl polyethylene glycol dendrimer targets activated glia in multiple CNS disorders.
    Sharma A; Sharma R; Zhang Z; Liaw K; Kambhampati SP; Porterfield JE; Lin KC; DeRidder LB; Kannan S; Kannan RM
    Sci Adv; 2020 Jan; 6(4):eaay8514. PubMed ID: 32010790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model.
    Kannan S; Dai H; Navath RS; Balakrishnan B; Jyoti A; Janisse J; Romero R; Kannan RM
    Sci Transl Med; 2012 Apr; 4(130):130ra46. PubMed ID: 22517883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface functionality affects the biodistribution and microglia-targeting of intra-amniotically delivered dendrimers.
    Zhang F; Nance E; Zhang Z; Jasty V; Kambhampati SP; Mishra MK; Burd I; Romero R; Kannan S; Kannan RM
    J Control Release; 2016 Sep; 237():61-70. PubMed ID: 27378700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minocycline plus N-acetylcysteine synergize to modulate inflammation and prevent cognitive and memory deficits in a rat model of mild traumatic brain injury.
    Haber M; Abdel Baki SG; Grin'kina NM; Irizarry R; Ershova A; Orsi S; Grill RJ; Dash P; Bergold PJ
    Exp Neurol; 2013 Nov; 249():169-77. PubMed ID: 24036416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cells.
    Kambhampati SP; Mishra MK; Mastorakos P; Oh Y; Lutty GA; Kannan RM
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):239-49. PubMed ID: 25701805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendrimer-drug conjugates for tailored intracellular drug release based on glutathione levels.
    Navath RS; Kurtoglu YE; Wang B; Kannan S; Romero R; Kannan RM
    Bioconjug Chem; 2008 Dec; 19(12):2446-55. PubMed ID: 19053299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.